Cervix News and Research

RSS

First drug treatment for late-stage cervical cancer approved

FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.

18 Jun 2006

FDA approval of Gardasil to prevent cervical cancer

The Food and Drug Administration (FDA) has announced the approval of Gardasil, the first vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to human papillomavirus (HPV) types 6, 11, 16 and 18.

8 Jun 2006

Human Papillomavirus testing and liquid-based cytology

Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions of the cervix, a study in the Journal of the National Cancer Institute reports.

7 Jun 2006

Sex during pregnancy myth debunked

A new study debunks the widely held belief that engaging in sexual intercourse during the final weeks of pregnancy can hasten labor and delivery.

1 Jun 2006

IVF puts woman and fetus at risk of placenta disorder

Researchers say that women who have IVF treatment are more likely to suffer a potentially life-threatening condition than those who conceive naturally.

25 May 2006

Total versus subtotal hysterectomy for benign gynaecological conditions

Women who undergo a total hysterectomy, in which both the uterus and the cervix are removed, are no more likely to experience sexual difficulties or urinary or bowel problems after surgery than women who have only their uterus removed, a new review has found.

23 May 2006

Abortion pill in trouble again

Clostridium sordellii is a rare germ that has killed four women who took the abortion pill RU-486 and has also been implicated in the deaths of at least 11 other women following childbirth or miscarriage.

11 May 2006

Skin cancer facts

Up to two-thirds of all cancers may be prevented through dietary and lifestyle changes. In the case of skin cancer, this could not be more true.

4 Apr 2006

Link between lead and osteoporosis strengthens

Bolstered by recent laboratory findings, researchers at the University of Rochester Medical Center are embarking on a National Institutes of Health-funded clinical study to better understand the deceptive role environmental lead exposure plays in bone maturation and loss.

4 Apr 2006

HPV vaccines provide hope for major international programmes of primary prevention

Parents of young girls may soon be offered the opportunity to have their daughters immunised against a sexually transmitted virus that is the major cause of cervical cancer, the 4th International Conference on Teenage and Young Adult Cancer Medicine.

3 Apr 2006

Human papillomavirus may be a risk factor in developing squamous cell carcinoma

The study, published in the March 15 issue of the Journal of the National Cancer Institute, used new technology to detect antibodies from a strain of HPV on skin cancer samples.

20 Mar 2006

New vaccines will protect against cancer

The leading cancer charity in Britain is predicting that thousands of cancers will be prevented every year as specific vaccines are developed.

13 Mar 2006

BRCA1 gene inhibits estrogen and progesterone

It's been known that the breast cancer susceptibility gene BRCA1 regulates use of estrogen in breast and other cells, but now researchers at Georgetown University Medical Center have discovered that it also controls activity of a second sex steroid hormone, progesterone.

27 Jan 2006

Micro-gyroscopes could detect, monitor and provide therapy guidance on cancer

A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.

22 Dec 2005

Two tests in a lifetime will halve cervical cancer numbers in poor countries

Most women in developed countries are regularly screened for cervical cancer, but this is often not the case in poorer countries.

20 Nov 2005

Rapid screen-and-treat methods significantly reduce cervical cancer precursor lesions

A new study led by Columbia University Medical Center researchers demonstrates the safety and efficacy of two low-tech diagnostic tools to significantly reduce the prevalence of cervical cancer precursor lesions.

3 Nov 2005

Study examines cancer risks after cancer diagnosis in family

After a person is diagnosed with cancer, increased surveillance among their family members may result in the earlier detection of asymptomatic familial cancers.

3 Nov 2005

"Screen and treat” cervical cancer programs effective in poorly resourced areas

According to a new study two "screen and treat" cervical cancer prevention programs developed for high-risk women in low-resource settings resulted in a lower prevalence of precancerous cervical lesions and cervical cancer, according to a study in the November 2 issue of JAMA: The Journal of the American Medical Association.

2 Nov 2005

Cervical cancer vaccine shows promising results but smear tests still vital

Hopes of an end to routine smear testing have been raised by promising results achieved by a prototype cervical cancer vaccine.

16 Oct 2005

Liver services in the United Kingdom need better funding and better staffing

Mortality from liver disease is increasing in the UK. In 2000 liver disease killed more men than Parkinson's disease and more women than cancer of the cervix. Deaths from alcoholic liver disease has doubled in the past 10 years, while liver disease arising from hepatitis C infection is expected to treble by 2020.

13 Oct 2005